Patent Law Update - What IP Practitioners Need to Know in 2016

Holland & Hart is proud to be participating in the “Patent Law Update - What IP Practitioners Need to Know in 2016” conference hosted by CLE International in Denver on January 25, 2016.

Leader of IP at Holland & Hart and Patent Law Update Program Chair Don Degnan will introduce the day, while Patent Partner Michael Drapkin will present on “Best Practices for a Future-Proof Application in an Unpredictable World”.

Michael’s session will focus on how recent changes at the PTO, in the courts, and the implementation of the AIA have dramatically changed the patent landscape and also the consistent themes that, when identified, illustrate a path toward a future-proof application.

Don and Michael will be joined by a number of impressive local speakers, including the newly appointed Regional Director of the Rocky Mountain USPTO, the Patent Trial and Appeal Board, the U.S. District Court of Colorado, leading in-house patent counsel, and other nationally recognized patent lawyers.

Topics covered at the event will include:

  • Case Law Updates, including Teva Pharm. USA, Inc. v. Sandoz, Inc.
  • Strategies, Trends, and Updates in Defending NPE Patent Suits
  • Local Patent Rules for the District of Colorado
  • Best Practices for a Future-Proof Application
  • Rocky Mountain USPTO Updates
  • Denver PTAB Trends, Rules of Practice, and Your Concerns
  • Best Practices before the U.S. District Court of Colorado
  • Damages in Patent Litigation

Attendance at the conference provides up to 7 Hours MCLE Credit.

To find out further details (including costs and timings), please click here to download the event brochure. Alternatively, please visit to register your attendance.

We look forward to seeing you there!


Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.